Reporter

Paul Sisson

Paul Sisson is a reporter for The San Diego Union-Tribune and has covered health care in San Diego County since 2010. He is a member of the Association of Health Care Journalists and earned a journalism degree from Augustana University.

People smoke marijuana as Kevin Bice, top, makes balloon animals and figures at the annual 4/20 gathering on Hippie Hill in Golden Gate Park, Monday, April 20, 2026, in San Francisco. (AP Photo/Jeff Chiu)

Marijuana study affirms drug’s negative effect on youth

April 21, 2026 at 4:37 p.m.

Analysis of data from 11,000 youth shows slower cognitive progress for those who used cannabis

Study detects dementia risk decades before symptoms appear

March 21, 2026 at 8:10 a.m.

Researchers examined blood samples collected in the 1990s to detect a key biomarker's presence.

A new clinical trial launched by Scripps Research will investigate using tirzepatide, a popular diabetes and weight loss drug made by Eli Lilly, to treat long COVID. This drug is marketed under the trade name Zepbound for weight loss and Mounjaro, pictured in the injectable pen form, for treating type 2 diabetes.

Can a weight loss and diabetes drug treat long COVID?

November 5, 2025 at 1:44 p.m.

New Scripps Research trial will explore the effects of Lilly's GLP-1 drug on reducing the symptoms of the debilitating disease.

Long-lasting insulin takes another step forward with latest clinical trial results

June 25, 2025 at 10:46 a.m.

Scripps researcher delivers findings for Lilly drug expected to request approval from FDA soon

3d illustration of the human heart and artery with high blood pressure and hypertension. (Getty)

Blood pressure-lowering medication shows promise in new trial results

April 29, 2025 at 12:51 p.m.

Hypertension is said to affect more than 120 million Americans.

a registered nurse attaches an IV line to the intravenous port implanted in Nicole Baca's chest

Nurse can’t shake COVID-19’s unrelenting grip: ‘I have lost relationships’

March 28, 2025 at 5:48 a.m.

New cases of the debilitating syndrome known as long COVID are still being diagnosed daily.

All Stories